Is the Outlook For Patients With Aggressive Breast Cancer Changing due to Immunotherapy?
Breast cancer is a type of cancer for which new immune-based cancer treatments are still under development. It is the most commonly diagnosed cancer in women worldwide and the most leading cause of cancer-related death among women. Breast cancer, in the metastasis stage, is an incurable disease with a survival rate of approximately 5 to 10 percent within five years. Immunotherapy has improved the survival of metastatic breast cancer patients with HER 2 receptor. Here are facts about triple negative breast cancer: • Triple negative is the most aggressive form of breast cancer that is likely to spread beyond the breast and is more likely to recur. • Triple negative means that the cancer is negative for estrogen, progesterone and HER 2. • The triple negative cancer tends to be of higher grade than other breast cancer types. When the grade is higher, the cancer cells reduce their resemblance to healthy breast cells both in appearance and patterns of growth. It is usually a ce